Andean Precious Metals (CVE:APM) Stock Price Down 10.4% - Here's What Happened

Andean Precious Metals Corp. (CVE:APM - Get Free Report) shares were down 10.4% on Tuesday . The company traded as low as C$1.12 and last traded at C$1.12. Approximately 535,049 shares traded hands during trading, an increase of 177% from the average daily volume of 193,465 shares. The stock had previously closed at C$1.25.

Analysts Set New Price Targets

Separately, Desjardins upgraded Andean Precious Metals to a "moderate buy" rating in a research note on Thursday, October 31st.

Andean Precious Metals Trading Down 10.4 %

The firm has a 50 day moving average of C$1.43 and a 200-day moving average of C$1.25. The company has a market cap of C$167.28 million, a P/E ratio of 2.95 and a beta of 1.22.

Insider Buying and Selling at Andean Precious Metals

In other Andean Precious Metals news, insider 2176423 Ontario Ltd. bought 84,400 shares of the business's stock in a transaction that occurred on Tuesday, October 8th. The stock was purchased at an average cost of C$1.51 per share, with a total value of C$127,359.60. In the last ninety days, insiders have purchased 306,200 shares of company stock worth $432,953. Insiders own 69.37% of the company's stock.

About Andean Precious Metals

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.